Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Avascular necrosis (AVN) is a disease resulting from a temporary or permanent loss of blood supply to the bones. It generally affects people between the ages of 30 and 50 years of age. This disease is also known as osteonecrosis, aseptic necrosis and ischemic bone necrosis. Avascular necrosis is the death of the bone marrow cells due to ischemia. In some cases, the bone will collapse. It affects the epiphysis of the long bones and is most commonly seen in the femur. Avascular necrosis has several causes, trauma is the most common cause of AVN. It can occur within eight hours after a traumatic injury. This report studies the global market for avascular necrosis in terms of revenue (USD million) from 2020 to 2025.
The global avascular necrosis market has gained profitable growth owing increasing awareness along with the high prevalence of the avascular necrosis disease. The market is further boosted by rising preference of surgeries to cure osteonecrosis and surging preference of bone grafting surgical procedures with the less pain substitute procedures. Moreover, the market is expected to show robust growth during the forecast period due to consolidation of large healthcare providers in the U.S and technological advancements in the development of surgical implants. Growing demand for non-invasive treatments for faster recovery is further expected to propel this market growth. However, the global avascular necrosis market is hindered by high cost of surgical procedures and related side effects coupled with worsening regulatory landscape & growing cost of noncompliance in developed countries.
The report analyses the global avascular necrosis market, based on type, site, diagnosis, treatment, end-user and geography.
The market is segmented into various type, which includes trauma-related avascular necrosis (AVN) and non-trauma related avascular necrosis (AVN). Among these, the trauma-related avascular necrosis segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to its surging prevalence.
The avascular necrosis is segmented into various sites such as, hip bone, knee, shoulder and other. Types of trauma associated or leading to AVN include fracture of the femoral neck, lipped capital femoral epiphysis, proximal femoral epiphysisiolysis, dislocated femoral head, epiphyseal compression, vascular trauma, radiation exposure and chronic renal failure.
The market is segmented into various diagnosis, which includes imaging such as X-Ray, CT scan, MRI, PET; and biopsy. Among these, the imaging segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to surging imaging techniques using avascular necrosis for various treatments.
The market is segmented into various treatment, which includes medication, electrical stimulation, gene therapy and surgery. The surgeries are further classified into core decompression, osteotomy, bone graft and arthoplasty. Among these, the gene therapy segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period.
The market is segmented into various end users, which includes hospitals & clinics, diagnostic centers and ambulatory surgical centers. Among these, the hospitals & clinics segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to surging number of hospitals providing treatment for avascular necrosis.
By geography, the global avascular necrosis market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America dominated the global avascular necrosis market in 2017, due to advanced hospitals infrastructures, and availability of skilled healthcare professionals. Presence of strong economic condition and huge development in the healthcare domain are further fuelling the market growth. Moreover, Asia Pacific is the anticipated to grow at a fastest growth rate during the forecast period 2019 to 2024 among other regions. The higher rate of the growth is fuelled by increasing emphasis on rapid diagnosis and treatment of avascular necrosis and increasing prevalence of avascular necrosis among population.
The demand for avascular necrosis market is gauzed by market attractiveness tool and company market share. The key players of global avascular necrosis market include Stryker Corporation, Medtronic plc, Ethicon Inc., Sanofi SA, Bayer AG, Pfizer Inc., Merck KGaA, Boehringer Ingelheim GmbH, Eli Lilly and Company, Aurobindo Pharma, Integra LifeSciences Corporation, Zimmer Biomet Holdings, Wright Medical Group N.V., Grifols SA and Smith and Nephew among others. Strategies such as product innovation and collaborations are adopted by global players as well as regional players, to maintain the product superiority, thus interpreting market sustainability.
The global avascular necrosis market is segmented based on type, site, diagnosis, treatment, end-user and geography. The market is segmented into various type, which includes trauma-related avascular necrosis (AVN) and non-trauma related avascular necrosis (AVN). Among these, the trauma-related avascular necrosis segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to its surging prevalence.
The avascular necrosis is segmented into various sites such as, hip bone, knee, shoulder and other. Types of trauma associated or leading to AVN include fracture of the femoral neck, lipped capital femoral epiphysis, proximal femoral epiphysisiolysis, dislocated femoral head, epiphyseal compression, vascular trauma, radiation exposure and chronic renal failure.
The market is segmented into various diagnosis, which includes imaging such as X-Ray, CT scan, MRI, PET; and biopsy. Among these, the imaging segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to surging imaging techniques using avascular necrosis for various treatments.
The market is segmented into various treatment, which includes medication, electrical stimulation, gene therapy and surgery. The surgeries are further classified into core decompression, osteotomy, bone graft and arthoplasty. The market is further segmented into various end users, which includes hospitals & clinics, diagnostic centers and ambulatory surgical centers. Among these, the hospitals & clinics segment dominated the market in 2017 and is expected to grow at a lucrative growth rate during the forecast period, due to surging number of hospitals providing treatment for avascular necrosis.
By geography, the global avascular necrosis market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America dominated the global avascular necrosis market in 2017, due to advanced hospitals infrastructures, and availability of skilled healthcare professionals.
Why to buy this report:
